Скачать или смотреть Buy or Sell Inovio Stock? | 2020 INO Stock Analysis

Inovio Pharmaceuticals (INO) stock is in the news this week after positive reports that their vaccine has begun Phase I testing. The obvious demand for such a drug is at peak levels with the current health threat, and Inovio investors are hoping to benefit from a spike in their stock price.

This video looks at INO stock from a buy or sell perspective. Does it make sense to invest in Inovio on the possibility of drug approval, or is the current race for a vaccine too crowded for the company to compete in? I discus the bull and bear case from both angles.

Stocks featured in this video:

Inovio Pharmaceuticals, Inc. (INO)
Moderna, Inc. (MRNA)

👉 Interest in learning more about the TipRanks service featured in all of my videos? Use my referral to support the channel and learn more:
https://40finance.com/tipranks

What are your thought on the latest news about Inovio? Do you think the stock will continue to rise, or flame out due to competition? Let me know in the comments!

Other 40 Finance videos you may like:

Should you buy GILD stock on Remdesivir news?
   • Don't Buy Gilead Stock on Remdesivir News ...  

4 Medical PPE Equipment Stocks to Watch in 2020
   • 4 Medical PPE Equipment Stocks to Watch in...  

Also visit my new digital marketing channel at    / geoffbeers